Fpquickreferencechart1b

Quick Reference Chart for the WHO Medical Eligibility Criteria for Contraceptive Use –
to initiate or continue use of combined oral contraceptives (COCs), depot-medroxyprogesterone acetate (DMPA), progestin-only implants, copper intrauterine device (Cu-IUD)
CONDITION
Implants Cu-IUD
CONDITION
Implants Cu-IUD
Pregnancy
Gestational
trophoblastic
Breastfeeding
Persistently elevated β-hCG levels or malignant disease Postpartum
< 48 hours including immediate post-placental Breast disease
Past w/ no evidence of current disease for 5 yrs Postabortion
Uterine distortion due to fibroids or anatomical abnormalities
STIs/PID
Current purulent cervicitis, chlamydia, gonorrhea Multiple risk factors for cardiovascular disease
Hypertension
History of (where BP cannot be evaluated) Elevated BP (systolic 140 - 159 or diastolic 90 - 99) Very high individual risk of exposure to STIs Elevated BP (systolic ≥ 160 or diastolic ≥ 100) Pelvic tuberculosis
Diabetes
Deep venous
Vascular disease or diabetes for > 20 years thrombosis
Symptomatic gall bladder disease (current or medically treated)
(DVT) and
pulmonary
DVT/PE, established on anticoagulant therapy Cholestasis
embolism (PE)
Major surgery with prolonged immobilization (history of)
Known thrombogenic mutations
Hepatitis
Ischemic heart disease (current or history of) or stroke (history of)
Known hyperlipidemias
Cirrhosis
Complicated valvular heart disease
Systemic lupus
Positive or unknown antiphospholipid antibodies Liver tumors (hepatocellular adenoma and malignant hepatoma)
erythematosus
Headaches
Migraine without aura (age < 35 years) Drug interac-
Nucleoside reverse transcriptase inhibitors tions, including
Non-nucleoside reverse transcriptase inhibitors Ritonavir, ritonavir-boosted protease inhibitors bleeding
Heavy or prolonged, regular and irregular patterns
Unexplained bleeding (prior to evaluation) Category 1 There are no restrictions for use.
Category 2 Generally use; some follow-up may be needed.
I/C (Initiation/Continuation): A woman may fal into either one category or another, depending on whether she is initiating or continuing to use a method. For
example, a client with current PID who wants to initiate IUD use would be considered as Category 4, and should not have an IUD inserted. However, if she develops Category 3 Usual y not recommended; clinical judgment and
PID while using the IUD, she would be considered as Category 2. This means she could general y continue using the IUD and be treated for PID with the IUD in continuing access to clinical services are required for use.
place. Where I/C is not marked, the category is the same for initiation and continuation.
NA (not applicable): Women who are pregnant do not require contraception.
Category 4 The method should not be used.
NC
* Evaluation of an undiagnosed mass should be pursued as soon as possible.
** Anticonvulsants include: phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine,
and lamotrigine. Lamotrigine is a category 1 for implants.

Source: http://www.nurhi.org/sites/nurhi.k4health.org/files/FPQuickReferenceChart1b_0.pdf